BIIB067
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB067, covering 2023-07-28 to 2023-07-28. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) [Phase 3]